Crossmark

Gonadotropin releasing hormone analogue treatment of central precocious puberty is not associated with altered prevalence of polycystic ovary syndrome: a single center cohort study

Crossref DOI link: https://doi.org/10.1186/s40842-021-00129-4

Published Online: 2021-09-15

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Karavani, Gilad https://orcid.org/0000-0003-1848-4560
Chill, Henry H.

Schachter-Safrai, Natali

Lomnitz, Gan

Gillis, David

Bauman, Dvora
License Information

Text and Data Mining valid from 2021-09-15

Version of Record valid from 2021-09-15
More Information

Article History

Received: 11 November 2020

Accepted: 16 June 2021

First Online: 15 September 2021

Declarations

:

: The study was approved by the Human Research Ethics Committees of the Hadassah University hospital (IRB number HMO -192–19).) and conforms to the provisions of the declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below